Fiscal Year (FY) 2024 Notice of Supplemental Funding Opportunity, 68452-68453 [2024-18943]

Download as PDF 68452 Federal Register / Vol. 89, No. 165 / Monday, August 26, 2024 / Notices Dated: August 20, 2024. Ann Ferrero, Public Health Analyst. DEPARTMENT OF HEALTH AND HUMAN SERVICES Substance Abuse and Mental Health Services Administration [FR Doc. 2024–19021 Filed 8–23–24; 8:45 am] BILLING CODE 4162–20–P Fiscal Year (FY) 2024 Notice of Supplemental Funding Opportunity DEPARTMENT OF HEALTH AND HUMAN SERVICES Substance Abuse and Mental Health Services Administration, Department of Health and Human Services (HHS). AGENCY: Substance Abuse and Mental Health Services Administration Fiscal Year (FY) 2024 Notice of Supplemental Funding Opportunity Notice of intent to award supplemental funding. ACTION: This notice is to inform the public that the Substance Abuse and Mental Health Services Administration (SAMHSA) is supporting an administrative supplement in scope of the parent award for one eligible grant recipient funded under the FY 2023 Provider’s Clinical Support System— Medications for Opioid Use Disorder (PCSS–MOUD), Notice of Funding Opportunity (NOFO) TI–23–014. The recipient may receive up to $1,000,000. This supplement provides support to the recipient with a project end date of September 30, 2025. The supplemental funding will be used to support increased fees from the training platform service as a result of an increase in the number of practitioners accessing training from the program. SUMMARY: Patti Juliana, Substance Abuse and Mental Health Services Administration, 5600 Fishers Lane, Rockville, MD 20857, telephone 240–276–1195; email: patti.juliana@samhsa.hhs.gov. FOR FURTHER INFORMATION CONTACT: lotter on DSK11XQN23PROD with NOTICES1 SUPPLEMENTARY INFORMATION: Funding Opportunity Title: FY2024 Providers’ Clinical Support System— Medications for Opioid Use Disorder (PCSS-MOUD) TI–23–014. Assistance Listing Number: 93.243. Authority: Section 509 of the of the Public Health Service Act. Justification: The one SAMHSAfunded grant recipient of this NOFO has experienced increased fees from its training platform service as a result of an increase in the number of practitioners accessing training from the program. This is not a formal request for application. Assistance will only be provided to the one PCSS–MOUD grant recipient funded in FY 2023 under the Providers’ Clinical Support System— Medications for Opioid Use Disorder (PCSS–MOUD) [TI–23–014] based on the receipt of a satisfactory application and associated budget that is approved by a review group. VerDate Sep<11>2014 17:03 Aug 23, 2024 Jkt 262001 Substance Abuse and Mental Health Services Administration, Department of Health and Human Services (HHS). ACTION: Notice of intent to award supplemental funding. AGENCY: This notice is to inform the public that the Substance Abuse and Mental Health Services Administration (SAMHSA) is supporting administrative supplements in scope of the parent award for the 26 eligible grant recipients funded in FY 2022 under the First Responders-Comprehensive Addiction and Recovery Act (FR–CARA), Notice of Funding Opportunity (NOFO) TI–22– 008. Recipients may receive up to $58,190 each, for a total of $1,512,940 across the program. These recipients have a project end date for use of these supplemental funds of September 29, 2025. The supplements will be used to fund a Training of Trainer (ToT) model to rapidly expand workforce development and capacity in the arena of preventing overdose related deaths and adverse events within existing projects funded under the FR–CARA program. FOR FURTHER INFORMATION CONTACT: Shannon Hastings, NOFO Lead, Division of Targeted Prevention, Center for Substance Abuse Prevention, Substance Abuse and Mental Health Services Administration, 5600 Fishers Lane, Rockville, MD 20857, DTPNOFO@samhsa.hhs.gov, Telephone: (240) 276–1869. SUPPLEMENTARY INFORMATION: Funding Opportunity Title: FY 2022 First Responders-Comprehensive Addiction and Recovery Act (FR-CARA) TI–22–008. Assistance Listing Number: 93.243. Authority: Section 546 of the Public Health Service Act, as amended, 42 U.S.C. 290ee–1. Justification: These supplement awards will be offered to the FY 2022 cohorts under TI–22–008. Supplemental funding will be awarded to this cohort that has two years remaining in awards SUMMARY: PO 00000 Frm 00067 Fmt 4703 Sfmt 4703 to implement their projects. FY 2022 cohorts have implemented existing activities well positioned to be leveraged under the ToT model. These factors will benefit SAMHSA so that the agency will be able to track the effects of the ToT model over time. This work aligns with SAMHSA’s goals of expanding access to naloxone and other opioid overdose reversal medications and enhances SAMHSA’s naloxone saturation and overdose prevention efforts. This is not a formal request for application. Assistance will only be provided to the 26 FR–CARA grant recipients funded in FY 2022 under the First Responders-Comprehensive Addiction and Recovery Act NOFO (TI– 22–008) based on the receipt of a satisfactory application and associated budget that is approved by a review group. Dated: August 20, 2024. Ann Ferrero, Public Health Analyst. [FR Doc. 2024–18944 Filed 8–23–24; 8:45 am] BILLING CODE 4162–20–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Substance Abuse and Mental Health Services Administration Fiscal Year (FY) 2024 Notice of Supplemental Funding Opportunity Substance Abuse and Mental Health Services Administration, Department of Health and Human Services (HHS). ACTION: Notice of intent to award supplemental funding. AGENCY: This notice is to inform the public that the Substance Abuse and Mental Health Services Administration (SAMHSA) is supporting administrative supplements in scope of the parent award for the five eligible grant recipients funded in FY22 and FY23 under the Grants to Prevent Prescription Drug/Opioid Overdose Program (PDO), Notice of Funding Opportunity (NOFO) SP–21–002. Recipients may receive up to $279,266 each for a total of $1,396,330 across the program. These recipients have a project end date for use of these supplemental funds of September 29, 2025. The supplemental funding will be used to fund a comprehensive Training of Trainer (ToT) model to enhance workforce development and capacity in the arena of preventing prescription drug/ overdose related deaths and adverse SUMMARY: E:\FR\FM\26AUN1.SGM 26AUN1 Federal Register / Vol. 89, No. 165 / Monday, August 26, 2024 / Notices events within existing projects funded under the PDO program. DEPARTMENT OF HOMELAND SECURITY FOR FURTHER INFORMATION CONTACT: Coast Guard Shannon Hastings, NOFO Lead, Division of Targeted Prevention, Center for Substance Abuse Prevention, Substance Abuse and Mental Health Services Administration, 5600 Fishers Lane, Rockville, MD 20857, email: DTPNOFO@samhsa.hhs.gov, telephone: (240) 276–1869. SUPPLEMENTARY INFORMATION: Funding Opportunity Title: FY 2021 Grants to Prevent Prescription Drug/ Opioid Overdose-Related Deaths (PDO) SP–21–002. Assistance Listing Number: 93.243. Authority: Section 516 of the Public Health Service Act, as amended, 42 U.S.C. 290bb–22. Justification: These supplement awards will be offered to the FY22 and FY23 cohorts under SP–21–002. Supplemental funding will be awarded to these cohorts because they have over three years remaining in their awards to implement their projects. The cohorts, which are comprised of state grantees, will receive a larger supplemental award per recipient which will increase opportunity to implement the activities. These cohorts have implemented existing activities well positioned to be leveraged under the ToT model. These factors will benefit SAMHSA so that the agency will be able to track the effects of the ToT model over time. This work aligns with SAMHSA’s goals of expanding access to naloxone and other opioid overdose reversal medications and enhances SAMHSA’s naloxone saturation and overdose prevention efforts. This is not a formal request for application. Assistance will only be provided to the 5 PDO grant recipients funded in FY22 and FY23 under the Grants to Prevent Prescription Drug/ Opioid Overdose Program, NOFO (SP– 21–002) based on the receipt of a satisfactory application and associated budget that is approved by a review group. lotter on DSK11XQN23PROD with NOTICES1 Dated: August 20, 2024. Ann Ferrero, Public Health Analyst. [FR Doc. 2024–18943 Filed 8–23–24; 8:45 am] BILLING CODE 4162–20–P VerDate Sep<11>2014 17:03 Aug 23, 2024 Jkt 262001 [Docket No. USCG–2024–0431] National Commercial Fishing Safety Advisory Committee; September 2024 Meetings U.S. Coast Guard, Department of Homeland Security. ACTION: Notice of open Federal advisory committee meetings. AGENCY: The National Commercial Fishing Safety Advisory Committee (Committee) will conduct a series of meetings over two days to review, discuss, and make recommendations to the Secretary on matters relating to marine investigation cases and other relevant initiatives pertaining to commercial fishing vessels (CFVs). For more detailed information see section VI below. DATES: Meetings: The Committee will hold a meeting on Tuesday, September 10, 2024, from 9 a.m. until 5 p.m. Alaska Daylight Time (AKDT), and Wednesday, September 11, 2024, from 8 a.m. until 5 p.m. AKDT. Please note these meetings may close early if the Committee has completed its business. Comments and supporting documentation: To ensure your comments are received before the meetings, please submit your written comments no later than September 2, 2024. SUMMARY: These meetings will be held at the William A. Eagan Civic & Convention Center 555 W Fifth Avenue, Anchorage, Alaska 99501. https:// anchorageconventioncenters.com/egancenter/overview. The National Commercial Fishing Safety Advisory Committee is committed to ensuring all participants have equal access regardless of disability status. If you require reasonable accommodation due to a disability to fully participate, please email Mr. Jonathan Wendland at Jonathan.G.Wendland@uscg.mil or call at 202–372–1245 as soon as possible. Instructions: You are free to submit comments at any time, including orally at the meetings as time permits, but if you want your comment reviewed before the meetings, please submit your comments no later than September 2, 2024. We are particularly interested in comments regarding the topics in the ‘‘Agenda’’ section below. We encourage you to submit comments through Federal Decision Making Portal at ADDRESSES: PO 00000 Frm 00068 Fmt 4703 Sfmt 4703 68453 https://www.regulations.gov. To do so, go to https://www.regulations.gov, type USCG–2024–0431 in the search box and click ‘‘Search’’. Next, look for this document in the Search Results column, and click on it. Then click on the Comment option. If your material cannot be submitted using https:// www.regulations.gov, email the individual in the FOR FURTHER INFORMATION CONTACT section of this document for alternate instructions. You must include the docket number USCG– 2024–0431. Comments received will be posted without alteration at https:// www.regulations.gov including any personal information provided. You may wish to review the Privacy and Security Notice found via link on the homepage of https:// www.regulations.gov, and DHS’s eRulemaking System of Records notice (85 FR 14226, March 11, 2020). If you encounter technical difficulties with comment submission, contact the individual listed in the FOR FURTHER INFORMATION CONTACT section of this notice. Docket Search: Documents mentioned in this notice as being available in the docket, and all public comments, will be in our online docket at https:// www.regulations.gov, and can be viewed by following that website’s instructions. Additionally, if you go to the online docket and sign-up for email alerts, you will be notified when comments are posted. FOR FURTHER INFORMATION CONTACT: Mr. Jonathan Wendland, Alternate Designated Federal Officer of the National Commercial Fishing Safety Advisory Committee, telephone 202– 372–1245 or Jonathan.G.Wendland@ uscg.mil. SUPPLEMENTARY INFORMATION: Notice of these meetings is in compliance with the Federal Advisory Committee Act, (Pub. L. 117–286, 5 U.S.C. ch. 10). The National Commercial Fishing Safety Advisory Committee was authorized on December 4, 2018, by section 601 of the Frank LoBiondo Coast Guard Authorization Act of 2018, (Pub. L. 115– 282, 132 Stat. 4190), and is codified in 46 U.S.C. 15102. The Committee operates under the provisions of the Federal Advisory Committee Act and 46 U.S.C. 15109. The Committee provides advice and recommendations to the Secretary of Homeland Security through the Commandant of the U.S. Coast Guard, on matters relating to the safe operation of vessels including the matters of: (A) navigation safety; (B) safety equipment and procedures; (C) marine insurance; E:\FR\FM\26AUN1.SGM 26AUN1

Agencies

[Federal Register Volume 89, Number 165 (Monday, August 26, 2024)]
[Notices]
[Pages 68452-68453]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2024-18943]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Substance Abuse and Mental Health Services Administration


Fiscal Year (FY) 2024 Notice of Supplemental Funding Opportunity

AGENCY: Substance Abuse and Mental Health Services Administration, 
Department of Health and Human Services (HHS).

ACTION: Notice of intent to award supplemental funding.

-----------------------------------------------------------------------

SUMMARY: This notice is to inform the public that the Substance Abuse 
and Mental Health Services Administration (SAMHSA) is supporting 
administrative supplements in scope of the parent award for the five 
eligible grant recipients funded in FY22 and FY23 under the Grants to 
Prevent Prescription Drug/Opioid Overdose Program (PDO), Notice of 
Funding Opportunity (NOFO) SP-21-002. Recipients may receive up to 
$279,266 each for a total of $1,396,330 across the program. These 
recipients have a project end date for use of these supplemental funds 
of September 29, 2025. The supplemental funding will be used to fund a 
comprehensive Training of Trainer (ToT) model to enhance workforce 
development and capacity in the arena of preventing prescription drug/
overdose related deaths and adverse

[[Page 68453]]

events within existing projects funded under the PDO program.

FOR FURTHER INFORMATION CONTACT: Shannon Hastings, NOFO Lead, Division 
of Targeted Prevention, Center for Substance Abuse Prevention, 
Substance Abuse and Mental Health Services Administration, 5600 Fishers 
Lane, Rockville, MD 20857, email: [email protected], telephone: 
(240) 276-1869.

SUPPLEMENTARY INFORMATION: 
    Funding Opportunity Title: FY 2021 Grants to Prevent Prescription 
Drug/Opioid Overdose-Related Deaths (PDO) SP-21-002.
    Assistance Listing Number: 93.243.
    Authority: Section 516 of the Public Health Service Act, as 
amended, 42 U.S.C. 290bb-22.
    Justification: These supplement awards will be offered to the FY22 
and FY23 cohorts under SP-21-002. Supplemental funding will be awarded 
to these cohorts because they have over three years remaining in their 
awards to implement their projects. The cohorts, which are comprised of 
state grantees, will receive a larger supplemental award per recipient 
which will increase opportunity to implement the activities. These 
cohorts have implemented existing activities well positioned to be 
leveraged under the ToT model. These factors will benefit SAMHSA so 
that the agency will be able to track the effects of the ToT model over 
time. This work aligns with SAMHSA's goals of expanding access to 
naloxone and other opioid overdose reversal medications and enhances 
SAMHSA's naloxone saturation and overdose prevention efforts.
    This is not a formal request for application. Assistance will only 
be provided to the 5 PDO grant recipients funded in FY22 and FY23 under 
the Grants to Prevent Prescription Drug/Opioid Overdose Program, NOFO 
(SP-21-002) based on the receipt of a satisfactory application and 
associated budget that is approved by a review group.

    Dated: August 20, 2024.
Ann Ferrero,
Public Health Analyst.
[FR Doc. 2024-18943 Filed 8-23-24; 8:45 am]
BILLING CODE 4162-20-P

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.